» Articles » PMID: 22461615

Rapamycin-induced Insulin Resistance is Mediated by MTORC2 Loss and Uncoupled from Longevity

Overview
Journal Science
Specialty Science
Date 2012 Mar 31
PMID 22461615
Citations 657
Authors
Affiliations
Soon will be listed here.
Abstract

Rapamycin, an inhibitor of mechanistic target of rapamycin complex 1 (mTORC1), extends the life spans of yeast, flies, and mice. Calorie restriction, which increases life span and insulin sensitivity, is proposed to function by inhibition of mTORC1, yet paradoxically, chronic administration of rapamycin substantially impairs glucose tolerance and insulin action. We demonstrate that rapamycin disrupted a second mTOR complex, mTORC2, in vivo and that mTORC2 was required for the insulin-mediated suppression of hepatic gluconeogenesis. Further, decreased mTORC1 signaling was sufficient to extend life span independently from changes in glucose homeostasis, as female mice heterozygous for both mTOR and mLST8 exhibited decreased mTORC1 activity and extended life span but had normal glucose tolerance and insulin sensitivity. Thus, mTORC2 disruption is an important mediator of the effects of rapamycin in vivo.

Citing Articles

Metabolic reprogramming in cancer and senescence.

Zhang Y, Tang J, Jiang C, Yi H, Guang S, Yin G MedComm (2020). 2025; 6(3):e70055.

PMID: 40046406 PMC: 11879902. DOI: 10.1002/mco2.70055.


Protein Arginine Methyltransferase 1: A Multi-Purpose Player in the Development of Cancer and Metabolic Disease.

de Korte D, Hoekstra M Biomolecules. 2025; 15(2).

PMID: 40001488 PMC: 11852820. DOI: 10.3390/biom15020185.


Ginkgolide B increases healthspan and lifespan of female mice.

Lee C, Wang B, Wong S, Chen Y, Cao Q, Hsiao A Nat Aging. 2025; 5(2):237-258.

PMID: 39890935 DOI: 10.1038/s43587-024-00802-0.


An mTOR inhibitor discovery system using drug-sensitized yeast.

Breen A, Thomas S, Beckett D, Agsalud M, Gingras G, Williams J Geroscience. 2025; .

PMID: 39885115 DOI: 10.1007/s11357-025-01534-8.


A novel rapalog shows improved safety vs. efficacy in a human organoid model of polycystic kidney disease.

Gulieva R, Ahmadvand P, Freedman B Stem Cell Reports. 2025; 20(2):102395.

PMID: 39855202 PMC: 11864154. DOI: 10.1016/j.stemcr.2024.102395.


References
1.
Colman R, Anderson R, Johnson S, Kastman E, Kosmatka K, Beasley T . Caloric restriction delays disease onset and mortality in rhesus monkeys. Science. 2009; 325(5937):201-4. PMC: 2812811. DOI: 10.1126/science.1173635. View

2.
Laplante M, Festuccia W, Soucy G, Gelinas Y, Lalonde J, Berger J . Mechanisms of the depot specificity of peroxisome proliferator-activated receptor gamma action on adipose tissue metabolism. Diabetes. 2006; 55(10):2771-8. DOI: 10.2337/db06-0551. View

3.
Kumar A, Lawrence Jr J, Jung D, Ko H, Keller S, Kim J . Fat cell-specific ablation of rictor in mice impairs insulin-regulated fat cell and whole-body glucose and lipid metabolism. Diabetes. 2010; 59(6):1397-406. PMC: 2874700. DOI: 10.2337/db09-1061. View

4.
Teutonico A, Schena P, Di Paolo S . Glucose metabolism in renal transplant recipients: effect of calcineurin inhibitor withdrawal and conversion to sirolimus. J Am Soc Nephrol. 2005; 16(10):3128-35. DOI: 10.1681/ASN.2005050487. View

5.
Cybulski N, Polak P, Auwerx J, Ruegg M, Hall M . mTOR complex 2 in adipose tissue negatively controls whole-body growth. Proc Natl Acad Sci U S A. 2009; 106(24):9902-7. PMC: 2700987. DOI: 10.1073/pnas.0811321106. View